David Harris, MD
Spinal Cord Injury Medicine · Austin, TXNPI 1710935093
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 60.4% of it on its own, with 18 other manufacturers making up the rest.
Across 129 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Pacira Therapeutics, Inc.$204
- Si-bone, Inc.$186
- Bioventus LLC$102
- Smith+Nephew$80
- Collegium Pharmaceutical, Inc.$62
- plus $374 from 13 others
What the payments were for
- Food & beverage$2,546100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 85 | $1,538 |
| Pacira Therapeutics, Inc. | 16 | $204 |
| Si-bone, Inc. | 3 | $186 |
| Bioventus LLC | 3 | $102 |
| Smith+Nephew | 1 | $80 |
| Collegium Pharmaceutical, Inc. | 3 | $62 |
| Amgen | 3 | $55 |
| Stryker | 1 | $53 |
| Lumenis, Inc | 1 | $47 |
| Pfizer | 2 | $39 |
| Teleflex LLC | 2 | $38 |
| Johnson & Johnson | 1 | $28 |
| Galderma Laboratories, L.p. | 2 | $24 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Medtronic | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
How this compares
Too few spinal cord injury medicine providers in Texasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 197 | $2,678 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 49 | $1,089 |
| Morphine Sulfate ErMorphine Sulfate | 13 | $354 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 22 | $133 |
| Tramadol Hcl | 26 | $76 |
Paid to pharmacies, not to this prescriber.
Other spinal cord injury medicine in Austin
- Tanisha ToastonArlington$1K
- Radha KorupoluHouston$547
- Seema SikkaDallas$203
- Isaac Hernandez JimenezHouston$181
- Angela VroomanSan Antonio$139
- Felicia SkeltonHouston$116
- Jennifer YangDallas$113
- Jennifer HarrisonHouston$87
- Matthew DavisHouston$23
- Maria Dajoyag-MejiaHouston$16
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.